-
ADAP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Adaptimmune Therapeutics (ADAP)
Company Profile
Quarter (USD) | Sep 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 42 |
Opened positions | 15 |
Closed positions | 40 |
Increased positions | 9 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 93.64 bn |
Total shares | 198.53 mm |
Total puts | 36.50 k |
Total calls | 78.50 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
New Enterprise Associates 14 | 102.48 mm | $150.64 mm |
EcoR1 Capital | 27.40 mm | $26.72 bn |
NEA Management | 17.08 mm | $16.65 bn |
Baillie Gifford & Co | 15.15 mm | $14.77 bn |
Partner Fund Management | 10.52 mm | $10.26 bn |
MPM Asset Management | 5.56 mm | $5.42 bn |
MPM Oncology Impact Management | 5.10 mm | $4.97 bn |
BAC Bank of America | 4.65 mm | $4.53 bn |
Rock Springs Capital Management | 2.43 mm | $2.36 bn |
Baker Bros. Advisors | 2.34 mm | $2.28 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 24 | Furey John | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 660,000 | 105.60 k | 660,000 |
1 Jul 24 | Alleva Lawrence M | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 1,213,926 | 194.23 k | 1,213,926 |
1 Jul 24 | Kristen Hege | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 660,000 | 105.60 k | 660,000 |
1 Jul 24 | Behbahani Ali | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 1,144,686 | 183.15 k | 1,144,686 |
1 Jul 24 | Priti Hegde | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 1,144,686 | 183.15 k | 1,144,686 |